Published in Am J Surg on January 01, 1980
The Eck fistula in animals and humans. Curr Probl Surg (1983) 2.35
Ten years portal hypertensive surgery at Emory. Results and new perspectives. Ann Surg (1982) 1.78
Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding. Preliminary report of a prospective, randomized trial. Ann Surg (1986) 1.62
The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up. Ann Surg (1985) 1.50
Hemodynamic differences between alcoholic and nonalcoholic cirrhotics following distal splenorenal shunt--effect on survival? Ann Surg (1983) 1.42
Selective shunt in the management of variceal bleeding in the era of liver transplantation. Ann Surg (1992) 1.18
Shunt surgery versus endoscopic sclerotherapy for long-term treatment of variceal bleeding. Early results of a randomized trial. Ann Surg (1987) 1.13
Noncirrhotic portal vein thrombosis. Physiology before and after shunts. Ann Surg (1980) 1.08
Partial versus total portacaval shunt in alcoholic cirrhosis. Results of a prospective, randomized clinical trial. Ann Surg (1994) 1.02
Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. First stage of a randomized, controlled trial. Ann Surg (1990) 0.94
Splenopancreatic disconnection. Improved selectivity of distal splenorenal shunt. Ann Surg (1986) 0.94
Exclusion of nonisolated splenic vein in distal splenorenal shunt for prevention of portal malcirculation. Ann Surg (1984) 0.91
Selective shunt versus nonshunt surgery for management of both schistosomal and nonschistosomal variceal bleeders. Ann Surg (1990) 0.90
Clinical analysis of surgical treatment of portal hypertension. World J Gastroenterol (2005) 0.87
The incidence and natural history of thrombus in the portal vein following distal splenorenal shunt. Ann Surg (1982) 0.87
Distal splenorenal shunt with splenopancreatic disconnection. A 4-year assessment. Ann Surg (1989) 0.87
Change in hepatic function, hemodynamics, and morphology after liver transplant. Physiological effect of therapy. Ann Surg (1989) 0.85
Factors affecting immediate and long-term survival after emergent and elective splanchnic-systemic shunts. Ann Surg (1985) 0.83
Predictability and maintenance of portal flow patterns after small-diameter portacaval H-grafts in man. Ann Surg (1984) 0.79
Improved quality of life after distal splenorenal shunt. A prospective comparison with side-to-side portacaval shunt. Ann Surg (1988) 0.79
Schistosomal versus nonschistosomal variceal bleeders. Do they respond differently to selective shunt (DSRS)? Ann Surg (1989) 0.78
Natural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: a lesson from the past. World J Gastroenterol (2006) 0.77
Operations for management of esophageal variceal hemorrhage. West J Med (1982) 0.76
Distal splenorenal shunt (DSS) in children: analysis of the first 21 consecutive cases. Ann Surg (1982) 0.75
Total parenteral nutrition with F080 in cirrhotics with subclinical encephalopathy. Ann Surg (1983) 0.75
An evaluation of splenopancreatic disconnection as a modification of the distal splenorenal shunt, studied in nonalcoholic patients by sequential angiography. Surg Today (1997) 0.75
Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice. Br J Gen Pract (1995) 6.43
Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg (1967) 5.62
A randomized, controlled trial of the distal splenorenal shunt. Ann Surg (1978) 2.15
Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. Clin Exp Rheumatol (2007) 2.12
Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med (1979) 2.11
The Family Health Project: psychosocial adjustment of children whose mothers are HIV infected. J Consult Clin Psychol (1998) 2.03
The role of a medical faculty in reorganizing family practice to meet current community needs. Can Med Assoc J (1970) 2.03
Generalists in medicine. BMJ (1994) 2.01
The relationship of antenatal and postnatal factors to sudden unexpected death in infancy. Can Med Assoc J (1966) 1.93
Asymptomatic hypercholesterolaemia. BMJ (1991) 1.92
Asymmetric methylation in the hypermethylated CpG promoter region of the human L1 retrotransposon. J Biol Chem (1997) 1.89
Controversies in the management of non-small cell lung cancer: the results of an expert surrogate study. Radiother Oncol (1990) 1.88
Do we need thyroid follow-up registers? A cost-effective study. Lancet (1982) 1.87
Ten years portal hypertensive surgery at Emory. Results and new perspectives. Ann Surg (1982) 1.78
Selective and total shunts in the treatment of bleeding varices. A randomized controlled trial. N Engl J Med (1976) 1.77
Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial. Ann Intern Med (1990) 1.75
Selective distal splenorenal shunt. Technique and results of operation. Arch Surg (1974) 1.74
Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol (2001) 1.73
Clinical trials in cancer: the role of surrogate patients in defining what constitutes an ethically acceptable clinical experiment. Br J Cancer (1989) 1.68
Cost of primary health care services in the emergency department and the family physician's office. Can Med Assoc J (1975) 1.65
Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding. Preliminary report of a prospective, randomized trial. Ann Surg (1986) 1.62
Male and female chronic pain patients categorized by DSM-III psychiatric diagnostic criteria. Pain (1986) 1.61
Hemodynamic contrasts between selective and total portal-systemic decompression. Ann Surg (1971) 1.58
Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res (1995) 1.58
Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem (1997) 1.54
Open treatment of pancreatic abscess. Surg Gynecol Obstet (1984) 1.53
Pancreatic ascites: diagnosis and management with particular reference to surgical technics. Ann Surg (1973) 1.53
Further epidemiologic observations on sudden, unexpected death in infancy in Ontario. Can J Public Health (1971) 1.53
Plasma concentrations of immunoreactive atrial natriuretic peptide in hospitalized cirrhotic and noncirrhotic patients: evidence for a role of deficient atrial natriuretic peptide in pathogenesis of cirrhotic ascites. Am J Gastroenterol (1988) 1.53
Associations of demographic, functional, and behavioral characteristics with activity-related fear of falling among older adults transitioning to frailty. J Am Geriatr Soc (2001) 1.52
Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. Gene (1998) 1.50
The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up. Ann Surg (1985) 1.50
Hermes, a functional non-Drosophilid insect gene vector from Musca domestica. Genetics (1996) 1.47
Glucose turnover values in the dog obtained with various species of labeled glucose. Am J Physiol (1975) 1.45
ON THE MAGNETIC ASYMMETRY OF MUSCLE FIBERS. Proc Natl Acad Sci U S A (1958) 1.45
Sexual factors in the epidemiology of cancer of the prostate. J Chronic Dis (1971) 1.44
Hemodynamic differences between alcoholic and nonalcoholic cirrhotics following distal splenorenal shunt--effect on survival? Ann Surg (1983) 1.42
Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein. J Biol Chem (1998) 1.40
Primary care for nontraumatic illness at the emergency department and the family physician's office. Can Med Assoc J (1976) 1.40
An analysis of morbidity in a hospital-based family practice. Can Fam Physician (1973) 1.39
Increasing overall physical activity and aerobic fitness is associated with improvements in metabolic risk: cohort analysis of the ProActive trial. Diabetologia (2008) 1.39
Glucose uptake and production during the oral glucose tolerance test. Diabetes (1968) 1.38
Glucose metabolism and plasma insulin level during epinephrine infusion in the dog. Am J Physiol (1967) 1.36
Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J Gen Virol (1999) 1.35
Sudden, unexpected death in infancy in Ontario. I. Methodology and findings related to the host. Can J Public Health (1967) 1.33
Renal decapsulation in the prevention of post-ischemic oliguria. Ann Surg (1977) 1.33
Maximal rates of excretion and synthesis of urea in normal and cirrhotic subjects. J Clin Invest (1973) 1.32
Further evaluation of selective decompression of varices by distal splenorenal shunt. Ann Surg (1969) 1.30
Preoperative assessment of portal hypertension. Ann Surg (1967) 1.28
STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination. J Immunol (1998) 1.27
The economics of specialist and general practitioner maternity units. J R Coll Gen Pract (1981) 1.26
The hobo transposable element of Drosophila can be cross-mobilized in houseflies and excises like the Ac element of maize. Proc Natl Acad Sci U S A (1993) 1.25
Evaluation of an evidence-based guideline for bronchiolitis. Pediatrics (1999) 1.23
Intrauterine herpes simplex virus infections. J Pediatr (1987) 1.22
Sudden, unexpected death in infancy in Ontario. II. Findings regarding season, clustering of deaths on specific days and weather. Can J Public Health (1967) 1.22
Reversal of hepatic encephalopathy after occlusion of total portasystemic shunts. Am J Surg (1981) 1.22
Survey of GP registrars' opinions of summative assessment and perceived effect on the training year. Br J Gen Pract (1999) 1.21
Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer (1989) 1.20
Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol (2000) 1.20
The metabolic basis of portasystemic encephalopathy and the effect of selective vs nonselective shunts. Ann Surg (1974) 1.19
Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation (1996) 1.19
Doctor/Patient contacts in family practice-an exploratory study. Can Fam Physician (1968) 1.17
Prevention of postoperative hemorrhage after pancreatic cystogastrostomy. Ann Surg (1973) 1.17
In-hospital cost of percutaneous coronary revascularization. Critical determinants and implications. Circulation (1995) 1.16
New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol (2013) 1.16
Elemental balances during intravenous hyperalimentation of underweight adult subjects. J Clin Invest (1975) 1.16
Prevalence and prediction of osteopenia in chronic liver disease. Hepatology (1990) 1.15
Enzyme-linked immunosorbent assay for detection of antibody to varicella-zoster virus. J Clin Microbiol (1982) 1.13
Diagnostic patterns and temporal trends in the evaluation of adult patients hospitalized with syncope. Arch Intern Med (2001) 1.11
Selective variceal decompression after splenectomy or splenic vein thrombosis. With a note on splenopancreatic disconnection. Ann Surg (1984) 1.10
Rerouting arterial flow to relieve ischemia: femoro-femoral, axillary femoral and carotid-carotid artery bypasses. Ann Surg (1966) 1.10
Pneumococcal polysaccharide immunization of children with sickle cell disease. II. Serologic response and pneumococcal disease following immunization. Am J Pediatr Hematol Oncol (1982) 1.09
Dacron interposition shunts for portal hypertension. An analysis of morbidity correlates. Ann Surg (1980) 1.09
Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice. Cancer Res (1995) 1.09
Functional domains of c-myc promoter binding protein 1 involved in transcriptional repression and cell growth regulation. Mol Cell Biol (1999) 1.09
Abdominal drainage following appendectomy and cholecystectomy. Ann Surg (1978) 1.09
Noncirrhotic portal vein thrombosis. Physiology before and after shunts. Ann Surg (1980) 1.08
Restoration of portal venous perfusion and reversal of encephalopathy by balloon occlusion of portal systemic shunt. Gastroenterology (1984) 1.07
Distal splenorenal shunt in treatment of bleeding esophageal varices in renal transplant recipients. Surg Gynecol Obstet (1984) 1.07
Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP. J Biol Chem (2000) 1.06
Management of variceal bleeding in patients with noncirrhotic portal vein thrombosis. Ann Surg (1988) 1.06
Transcription of repetitive sequences on Xenopus lampbrush chromosomes. Proc Natl Acad Sci U S A (1983) 1.06